Abstract Submission Guidelines
Abstract submission deadline: October 17, 2022, 11:59PM CST.
An individual may be the first author on a maximum of three (3) abstracts.
An individual may be a contributing author on an unlimited number of abstracts.
All submitted abstracts become the property of MDS.
Format
Text limit of 2,500 characters (including spaces). The size limit includes characters and spaces in the Abstract Title and Abstract Body. Please note that spaces are included in the overall character count. The size limit does not include author information.
Abstracts should be arranged as follows:
- Objective
- Background
- Methods
- Results
- Conclusions
*You may submit a case report using the standard abstract format
Do not include any identifying information directly on the abstract.
Drug names: Only non-proprietary (generic) drug names should be used and should be written without capitals. Do not include branded product names in the abstract. If the abstract is found to contain marketing, rather than scientific content, the abstract will be rejected.
Categories: Select one (1) category under which the abstract should be reviewed. If the abstract covers more than one topic, please choose the most appropriate category.
Abbreviations: Use standard abbreviations. A special or unusual abbreviation should be placed in parentheses after the first appearance of the full word for which it stands.
Tables and graphs: There is a separate upload field for tables and graphs. To include tables or figures, enter the appropriate ID tag within the abstract body where the tables and/or figures should appear. Tags must be entered as shown:
- [table1] for your first table
- [table2] for your second table
- [figure1] for your first figure
- [figure2] for your second figure.
Reference IDs: To list references, enter the appropriate ID tag:
- [1] for your first reference
- [2] for your second reference
- [3] for your third reference
- etc.
Submission
The sole means of submission is via the Internet. Please do not e-mail, fax, or mail abstract submissions.
Eligibility
Abstracts must be submitted and presented in English.
MDS members and non-members are eligible to submit abstracts.
There is no fee for submitting an MDS abstract.
MDS does not offer CME credit for poster viewing or submitted abstracts.
AOPMC faculty are not required to submit an abstract.
MDS expects that all accepted abstracts will be presented during the scheduled poster session time during the 8th AOPMC and that no submitted abstracts will be withdrawn. Please do not submit an abstract unless you are prepared to travel to the 8th AOPMC to present your abstract as a printed poster as scheduled by MDS.
All abstract presenters are required to register and pay applicable registration fees to attend the AOPMC.
Previously Published Abstracts and Plagiarism
All submitted abstracts will be run through an online plagiarism detection software. Should plagiarism be detected, the abstract will be rejected.
Abstracts that have been presented at other meetings may be submitted if they have not been previously published. Submitted abstracts that have been presented at other meetings must include the previous meeting name and presentation date cited accordingly in the abstract body, after the Conclusion.
If the abstract is found to have been previously published in another MDS publication or a previous edition of the Movement Disorders journal, the designated contact person will be notified and required to revise the abstract, or the abstract will be rejected.
All abstracts presented at a previous MDS International Congress or MDS regional meeting, such as the AOPMC or PAS Congress, have been published by MDS.
MDS does not republish previously published abstracts.
Review and Categorization
The AOPMC Scientific Program Committee will review all abstracts in November of 2022. The Committee shall be directed to reject abstracts for the following reasons:
- Plagiarism detected
- Marketing detected
- Subject not related to the field of Movement Disorders
- Does not meet basic requirements
All submitted abstracts will be run through an online plagiarism detection software. Should plagiarism be detected, the abstract will be rejected.
E-booklet PDF Submission
Please visit https://catalyst.omnipress.com by January 31, 2023 to view and submit a PDF of your poster for inclusion in an online supplement booklet. All supplemental booklet materials are due January 31, 2023 (extensions will not be granted).
Format: Only PDF files will be accepted.
Number of pages: PDF poster must be kept to 1 page per abstract.
File size: 150 MB maximum file size.
Content: PDF must include the corresponding abstract as accepted, without changes that modify the outcome of the originally submitted abstract. Please ensure poster content is scientific in nature and refrain from including marketing or promotional materials.